Straipsniai su viešo pasiekiamumo įpareigojimais - John M. LamarSužinokite daugiau
Niekur nepasiekiama: 3
Loss of CDKN2A Cooperates with WWTR1(TAZ)–CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
CN Seavey, A Hallett, S Li, K Che, AV Pobbati, S Ma, A Burtscher, ...
Clinical Cancer Research 29 (13), 2480-2493, 2023
Įpareigojimai: US Department of Defense
Keratinocyte integrin α3β1 induces expression of the macrophage stimulating factor, CSF-1, through a YAP/TEAD-dependent mechanism.
WM Longmate, E Norton, GA Duarte, L Wu, MR DiPersio, JM Lamar, ...
Matrix Biology 127, 48-56, 2024
Įpareigojimai: US National Institutes of Health
Organelle-based breast cancer cell classification with deep learning and visual explanations
H Yee, K Matteson, J Goldwag, JM Lamar, M Barroso, X Intes, U Kruger
Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XXII …, 2024
Įpareigojimai: US National Institutes of Health
Kur nors pasiekiama: 32
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
JM Lamar, P Stern, H Liu, JW Schindler, ZG Jiang, RO Hynes
Proceedings of the National Academy of Sciences 109 (37), E2441-E2450, 2012
Įpareigojimai: US National Institutes of Health, Howard Hughes Medical Institute
Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
A Naba, KR Clauser, JM Lamar, SA Carr, RO Hynes
elife 3, e01308, 2014
Įpareigojimai: US National Institutes of Health, Howard Hughes Medical Institute
A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis
NE Reticker-Flynn, DFB Malta, MM Winslow, JM Lamar, MJ Xu, ...
Nature communications 3 (1), 1122, 2012
Įpareigojimai: US National Institutes of Health, Howard Hughes Medical Institute
Tumor cell–driven extracellular matrix remodeling drives haptotaxis during metastatic progression
MJ Oudin, O Jonas, T Kosciuk, LC Broye, BC Guido, J Wyckoff, ...
Cancer discovery 6 (5), 516-531, 2016
Įpareigojimai: US National Institutes of Health, Howard Hughes Medical Institute
KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9
X Wang, H Lu, AM Urvalek, T Li, L Yu, J Lamar, CM DiPersio, PJ Feustel, ...
Oncogene 30 (16), 1901-1911, 2011
Įpareigojimai: US National Institutes of Health
Elucidation of the roles of tumor integrin β1 in the extravasation stage of the metastasis cascade
MB Chen, JM Lamar, R Li, RO Hynes, RD Kamm
Cancer research 76 (9), 2513-2524, 2016
Įpareigojimai: US National Science Foundation, US National Institutes of Health
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
JM Lamar, Y Xiao, E Norton, ZG Jiang, GM Gerhard, S Kooner, ...
Journal of Biological Chemistry 294 (7), 2302-2317, 2019
Įpareigojimai: US Department of Defense, US National Institutes of Health, Howard Hughes …
YAP/TAZ activation as a target for treating metastatic cancer
JSA Warren, Y Xiao, JM Lamar
Cancers 10 (4), 115, 2018
Įpareigojimai: Susan G. Komen
Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches
JD Hebert, SA Myers, A Naba, G Abbruzzese, JM Lamar, SA Carr, ...
Cancer research 80 (7), 1475-1485, 2020
Įpareigojimai: US Department of Defense, US National Institutes of Health, Howard Hughes …
Endothelial α3β1-integrin represses pathological angiogenesis and sustains endothelial-VEGF
RG Da Silva, B Tavora, SD Robinson, LE Reynolds, C Szekeres, J Lamar, ...
The American journal of pathology 177 (3), 1534-1548, 2010
Įpareigojimai: US National Institutes of Health, Cancer Research UK
RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer
M Kulkarni, TZ Tan, NBS Sulaiman, JM Lamar, P Bansal, J Cui, Y Qiao, ...
Oncotarget 9 (18), 14175, 2018
Įpareigojimai: US National Institutes of Health, National Research Foundation, Singapore
An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion
JM Lamar, KM Pumiglia, CM DiPersio
Cancer research 68 (18), 7371-7379, 2008
Įpareigojimai: US National Institutes of Health
MEF2 (myocyte enhancer factor 2) is essential for endothelial homeostasis and the atheroprotective gene expression program
YW Lu, N Martino, BD Gerlach, JM Lamar, PA Vincent, AP Adam, ...
Arteriosclerosis, thrombosis, and vascular biology 41 (3), 1105-1123, 2021
Įpareigojimai: US National Institutes of Health, American Heart Association, Susan G. Komen
Epithelioid hemangioendothelioma as a model of YAP/TAZ-driven cancer: insights from a rare fusion sarcoma
JM Lamar, V Motilal Nehru, G Weinberg
Cancers 10 (7), 229, 2018
Įpareigojimai: US Department of Veterans Affairs
Nephronectin is correlated with poor prognosis in breast cancer and promotes metastasis via its integrin-binding motifs
TS Steigedal, J Toraskar, RP Redvers, M Valla, SN Magnussen, AM Bofin, ...
Neoplasia 20 (4), 387-400, 2018
Įpareigojimai: US National Institutes of Health, Research Council of Norway
Radiation-induced macrophage senescence impairs resolution programs and drives cardiovascular inflammation
S Sadhu, C Decker, BE Sansbury, M Marinello, A Seyfried, J Howard, ...
The Journal of Immunology 207 (7), 1812-1823, 2021
Įpareigojimai: US National Institutes of Health, Leducq Foundation, USA
Complex Rab4-mediated regulation of endosomal size and EGFR activation
K Tubbesing, J Ward, R Abini-Agbomson, A Malhotra, A Rudkouskaya, ...
Molecular Cancer Research 18 (5), 757-773, 2020
Įpareigojimai: US National Institutes of Health, Susan G. Komen
Leidyklos ir finansavimo informaciją automatiškai nustato kompiuterio programa